Mineralocorticoid receptor antagonists use in patients with heart failure and impaired renal function

AIMS: Impaired renal function is a major contributor to the low proportion of mineralocorticoid receptor antagonist (MRA) treatment in patients with heart failure with reduced ejection fraction (HFrEF). Our aims were to investigate the impact of MRA treatment on all-cause mortality and worsening ren...

Descripción completa

Detalles Bibliográficos
Autores principales: Jonsson Holmdahl, Anna, Norberg, Helena, Valham, Fredrik, Bergdahl, Ellinor, Lindmark, Krister
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553049/
https://www.ncbi.nlm.nih.gov/pubmed/34710128
http://dx.doi.org/10.1371/journal.pone.0258949

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553049/
https://www.ncbi.nlm.nih.gov/pubmed/34710128
http://dx.doi.org/10.1371/journal.pone.0258949

Ejemplares similares